# Pancytopenia Concurrent With Metabolic Encephalopathy

## TL;DR

An 81-year-old woman with pancytopenia and metabolic encephalopathy was treated for kidney injury and electrolyte imbalances, with unresolved blood cell issues.

## Contribution

This case report highlights the rare co-occurrence of pancytopenia and metabolic encephalopathy, emphasizing monitoring for dehydration in patients on SGLT-2 inhibitors and diuretics.

## Key findings

- The patient's encephalopathy resolved after treating acute kidney injury and electrolyte imbalances.
- Pancytopenia remained unresolved despite transfusion and iron replacement therapy.
- Parvovirus B19 and myelodysplastic syndrome are suggested as possible causes of pancytopenia.

## Abstract

Pancytopenia is a decrease in the number of cells in all peripheral blood cell lines and has been associated with anemias, cancers, chemotherapy, infections, and nutritional deficiencies. However, pancytopenia concurrent with encephalopathy is rare and not well-studied. We present a case of pancytopenia concurrent with metabolic encephalopathy. An 81-year-old female patient presented to the emergency department for two weeks of increased fatigue and hypersomnolence. The patient had trouble staying awake during the initial physical exam, and her laboratory results were significant for pancytopenia, hypercreatinemia, hypernatremia, hypermagnesemia, and alkalemia. She was admitted to the floor, diagnosed with metabolic encephalopathy and acute kidney injury, and treated with medication withholding, fluid resuscitation, and electrolyte repletion. She also received a comprehensive workup for pancytopenia, iron replacement, and red blood cell transfusion therapy. After her metabolic encephalopathy was resolved, she was discharged with plans to follow up with hematology/oncology for stable but unresolved pancytopenia. We hypothesize that the patient’s metabolic encephalopathy was likely due to acute kidney injury-induced uremia or dehydration. We further hypothesize that parvovirus B19 and myelodysplastic syndrome are possible etiologies for pancytopenia. Our case highlights the importance of closely monitoring patients taking Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and loop diuretics for dehydration and subsequent organ failure.